153 related articles for article (PubMed ID: 27848185)
21. High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease.
Arimura K; Arima N; Matsushita K; Akimoto M; Park CY; Uozumi K; Tei C
J Clin Immunol; 2007 Mar; 27(2):145-51. PubMed ID: 17235688
[TBL] [Abstract][Full Text] [Related]
22. Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
Hamaki T; Kami M; Kim SW; Onishi Y; Kishi Y; Murashige N; Hori A; Kojima R; Sakiyama M; Imataki O; Heike Y; Tanosaki R; Masuo S; Miyakoshi S; Taniguchi S; Tobinai K; Takaue Y
Bone Marrow Transplant; 2004 May; 33(9):891-900. PubMed ID: 15048142
[TBL] [Abstract][Full Text] [Related]
23. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.
Ryu HJ; Seo MR; Choi HJ; Baek HJ
Korean J Intern Med; 2018 Sep; 33(5):1025-1031. PubMed ID: 28073242
[TBL] [Abstract][Full Text] [Related]
24. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
[TBL] [Abstract][Full Text] [Related]
25. Behcet's disease associated with malignancy: a report of 41 Chinese cases.
Lin Y; Li G; Zheng W; Tian X; Zhang F
Int J Rheum Dis; 2014 May; 17(4):459-65. PubMed ID: 24354961
[TBL] [Abstract][Full Text] [Related]
26. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
[TBL] [Abstract][Full Text] [Related]
27. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Scott BL; Sandmaier BM; Storer B; Maris MB; Sorror ML; Maloney DG; Chauncey TR; Storb R; Deeg HJ
Leukemia; 2006 Jan; 20(1):128-35. PubMed ID: 16270037
[TBL] [Abstract][Full Text] [Related]
28. [Successful cord blood transplantation for myelodysplastic syndrome with Behçet disease-like refractory stomatitis and multiple ileocecal ulcerations].
Kazumoto H; Ueki T; Kitahara M; Uematsu N; Shishido T; Kirihara T; Sato K; Hiroshima Y; Sumi M; Ueno M; Ichikawa N; Kobayashi H
Rinsho Ketsueki; 2019; 60(10):1436-1442. PubMed ID: 31695004
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features of Intestinal Behçet's Disease Associated with Myelodysplastic Syndrome and Trisomy 8.
Kawano S; Hiraoka S; Okada H; Akita M; Iwamuro M; Yamamoto K
Acta Med Okayama; 2015; 69(6):365-9. PubMed ID: 26690248
[TBL] [Abstract][Full Text] [Related]
30. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.
Nucci M; Garnica M; Gloria AB; Lehugeur DS; Dias VC; Palma LC; Cappellano P; Fertrin KY; Carlesse F; Simões B; Bergamasco MD; Cunha CA; Seber A; Ribeiro MP; Queiroz-Telles F; Lee ML; Chauffaille ML; Silla L; de Souza CA; Colombo AL
Clin Microbiol Infect; 2013 Aug; 19(8):745-51. PubMed ID: 23009319
[TBL] [Abstract][Full Text] [Related]
32. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
[TBL] [Abstract][Full Text] [Related]
34. Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
Shaffer BC; Le Luduec JB; Forlenza C; Jakubowski AA; Perales MA; Young JW; Hsu KC
Biol Blood Marrow Transplant; 2016 Apr; 22(4):705-709. PubMed ID: 26772158
[TBL] [Abstract][Full Text] [Related]
35. Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8.
Ahn JK; Cha HS; Koh EM; Kim SH; Kim YG; Lee CK; Yoo B
Rheumatology (Oxford); 2008 Aug; 47(8):1228-30. PubMed ID: 18550640
[TBL] [Abstract][Full Text] [Related]
36. Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML.
Lim ZY; Ingram W; Brand R; Ho A; Kenyon M; Devereux S; Marsh J; Mufti GJ; Pagliuca A
Bone Marrow Transplant; 2010 Apr; 45(4):633-9. PubMed ID: 19767782
[TBL] [Abstract][Full Text] [Related]
37. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.
Park J; Cheon JH; Park YE; Lee YJ; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
Int J Colorectal Dis; 2017 May; 32(5):745-751. PubMed ID: 27924367
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome.
Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
Stem Cells Dev; 2014 Jul; 23(14):1559-67. PubMed ID: 24617310
[TBL] [Abstract][Full Text] [Related]
40. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
